\nTether, the founder of the first, largest, and most widely \nused stablecoin USD₮, is rapidly expanding into a wide range of sectors,\n including secure and unstoppable communication technologies, energy \nproduction, mining, and further fintech infrastructure. All of these \nthemes share and are deeply rooted in the principles of Bitcoin, which \ninclude decentralization, resilience, openness, freedom, security, and \nscalability.\n\n\n\n\nTether stablecoins are used to power a wide variety of \nenterprises, including exchanges, wallets, payment processors, and \nfinancial services, by facilitating the use of reserve-backed tokens \nacross blockchain networks. Tether stablecoins offer a global, secure, \nand instant means of storing, transmitting, and receiving digital tokens\n at a fraction of the cost of alternative traditional financial \nsolutions. Unwavering transparency is of paramount importance and \ncentral to Tether's foundational principles.\n\n\n\n\nOur dynamic team operates entirely remotely, uniting talent\n from every corner of the globe. Our journey has been marked by rapid \ngrowth and efficient operations, firmly establishing us as pioneers \nwithin the industry.\n\n\n\n\nIf you possess a passion for venturing into uncharted \nterritory and believe in your ability to conquer even the most \nformidable challenges, we eagerly invite you to engage with us. Join our\n mission, and together, let's lay the groundwork for a decentralized \nfuture that reshapes industries far beyond the realm of stablecoins.\n\n\n\n\nAs the Senior Associate of Strategic Investments at Tether, you will play a pivotal role in our expansion into private equity investments, with a primary focus on the energy and mining sectors. Your expertise will be instrumental in identifying, evaluating, and executing investment opportunities that align with our strategic objectives. From deal analysis and due diligence to post-investment monitoring, you will be at the forefront of driving our investment initiatives forward.\n\n\n\n\nJob Requirements:\n\n\n* \nEducation and Certification: Bachelor's degree in Finance, Accounting, Economics, or related field. MBA or CFA designation preferred.\n\n* \nCorporate Finance Knowledge: Possess a strong understanding of corporate finance principles, including financial modeling, valuation techniques, and capital budgeting.\n\n* \nAccounting Acumen: Proficient in financial accounting standards and practices, with the ability to analyze financial statements and assess the financial health of potential investees.\n\n* \nDue Diligence Skills: Conduct comprehensive due diligence on potential investment targets, evaluating market dynamics, competitive positioning, regulatory environments, and other relevant factors.\n\n* \nAnalytical Thinking: Utilize strong analytical and critical-thinking skills to evaluate investment opportunities from multiple perspectives and identify key value drivers.\n\n* \nCommunication Skills: Exhibit excellent written and verbal communication skills in English, with the ability to effectively communicate findings and recommendations to senior management and investment committees.\n\n* \nTeam Collaboration: Work collaboratively with cross-functional teams, including legal, compliance, and operations, to execute investment transactions seamlessly.\n\n* \nDeal Making Expertise: Is a plus bot not required.\n\n\n\n\n\n* \nProficient in Microsoft Office 365 and G-Suite Products, particularly Microsoft Excel for financial analysis tasks.\n\n* \nDemonstrated critical-thinking skills, particularly in decision-making.\n\n* \nDemonstrated attention to detail in all aspects of work.\n\n* \nMinimum of 5 years of experience in private equity, investment banking, or corporate finance roles.\n\n* \nProficiency in financial analysis tools and software, such as Excel, Bloomberg, and financial modeling platforms.\n\n* \nStrong attention to detail and ability to manage multiple projects simultaneously.\n\n* \nEntrepreneurial mindset with a drive to identify and pursue new investment opportunities.\n\n* \nKnowledge of energy and mining sectors is a plus, but not required.\n\n\n\n\nJoin us at Tether as we embark on an exciting journey to shape the future of finance through strategic investments. Apply now to be a part of our innovative team driving global impact and growth. \n\n#Salary and compensation\n No salary data published by company so we estimated salary based on similar jobs related to Accounting, Finance, Senior and Non Tech jobs that are similar:\n\n $55,000 — $91,250/year\n
\n\n#Benefits\n 💰 401(k)\n\n🌎 Distributed team\n\n⏰ Async\n\n🤓 Vision insurance\n\n🦷 Dental insurance\n\n🚑 Medical insurance\n\n🏖 Unlimited vacation\n\n🏖 Paid time off\n\n📆 4 day workweek\n\n💰 401k matching\n\n🏔 Company retreats\n\n🏬 Coworking budget\n\n📚 Learning budget\n\n💪 Free gym membership\n\n🧘 Mental wellness budget\n\n🖥 Home office budget\n\n🥧 Pay in crypto\n\n🥸 Pseudonymous\n\n💰 Profit sharing\n\n💰 Equity compensation\n\n⬜️ No whiteboard interview\n\n👀 No monitoring system\n\n🚫 No politics at work\n\n🎅 We hire old (and young)\n\n
\n\n#Location\nRemote job

\nWho We Are:\n\n\nTechnology has transformed the way we work, communicate, travel, eat, move, and more. Yet in biopharma, it still takes 12 years to develop a single drug. Even today, thousands of diseases affecting hundreds of millions of people have no effective treatment. Accelerating the pace of bringing effective, new medicines to patients is one of the greatest opportunities for humanity. \n\n\nOur mission is to develop better drugs, faster using technology. We have built an end-to-end technology-driven drug discovery platform centered around one of the field’s largest human genomics databases in neuroscience. We use machine learning to map the complex causes of disease and turn those insights into promising drug candidates on our internal biology and chemistry platforms. We are developing drugs to treat some of the biggest medical challenges today: ALS, Parkinson’s Disease, and Alzheimer’s Disease.\n\n\nWe closed our Series C with a syndicate of top tier investors (e.g. BlackRock, Eli Lilly, Merck, Section 32, Threshold Ventures, Y Combinator, etc.). We are a team of engineers, neuroscientists, and drug developers united around an audacious vision: to build the next Genentech of the digital age. \n\n\nThe Chief Financial Officer is a strategic finance executive whose mission will be to ensure that Verge is capitalized to execute on our vision. You will report directly to our founder and CEO and sit on the executive leadership team. Partnering with the CEO, you will have the opportunity to rewrite the standard biotech financing playbook for tech-enabled drug discovery. You will drive external finance and strategy, lead internal resources and capital allocation decisions, and support strategic planning and operational decisions with data-driven analytics. You will oversee all sub-functional elements of finance, including FP&A, accounting, investor relations, transactions, and certain operational activities, including public relations, people, IT, and legal. \n\n\n\nYou will...\n* \n\n\nStrategic Finance \n* Own Verge's capital formation strategy\n* Prepare financing plans, evaluate creative financing strategies, generate options for accessing capital\n* Lead the preparation and execution of equity financings\n* Cultivate investor relationships; communicate the company story and progress\n* Develop long-range strategic plans, establish priorities, and identify opportunities to maximize shareholder value\n* Ensure company objectives are aligned with financing strategy and shareholder value creation\n\nFP&A\n* Own our long-term financial and operating model\n* Develop robust contingency plans and stress-tested financial models to manage costs effectively\n* Drive strategic decisions and timely implementation of cost reductions to ensure adequate runway\n* In partnership with the CBO, refine our BD strategy to focus on opportunities that maximize shareholder value\n* Oversee financial review of all transactions, including evaluation and prioritization of acquisitions, partnerships, collaborations, and in-licensing opportunities. Support the structuring, negotiation, and execution of these transactions.\n* Makes actionable recommendations on key transactions based on a prospective analysis of deal structure, financial impact, and long-term capital formation strategy. \n* Provide product support via financial analyses (e.g. market sizing, landscape analysis)\n* Negotiate with external partners and investors\n\nOperations\n* Manage all aspects of the finance and accounting functions; ensure maintenance of appropriate internal controls and financial procedures\n* Oversee investor relations, public relations, legal/compliance, and people functions\n* Keep investors, board, and shareholders informed of company financial status, results, budget, and forecastManage the audit committee\n* Proactively mitigate future risks and identifies new opportunities to improve capital efficiency\n* Drive a culture of financial discipline in managing the business. Facilitate tough conversations on strategic focus, reprioritization, and tradeoffs.\n\n\n\n12 month outcomes...\n* Strategic finance: Develop a Series D-enabling capital formation strategy (milestones, runway, financing), with multiple contingency plans\n* FP&A: Drive strategic decisions and implementation of cost reductions to ensure adequate runway to withstand uncertainty\n* Investor Relations: Cultivate>20 investors for our Series D financing\n* BD: Serve as a force multiplier for BD resulting in clearer strategy, faster decisions, greater focus, better outcomes\n* Other: Prepare Verge to be IPO-ready \n\n\n\nYou have...\n* > 10 years experience in a biotech investment banking or investor-facing environment\n* > 2 years operating experience at a biotech startup\n* Strong transactions deal sheet across BD, M&A, and/or financings, with experience facilitating non-traditional transactions\n* Deep understanding of equity capital markets (what investors want, when to finance/IPO, how markets operate) willingness to roll up their sleeves with hands-on executional FP&A and fundraising as needed\n* Experience setting milestones, developing long-range operating models and contingency plans\n* Strong financial modeling background with a fluent understanding of R&D project finance and FP&A nuances\n* A challenger who embraces discomfort and uncomfortable conversations\n* A natural “finisher” with strong attention to detail\n* An obsession with efficiency and killing complexity\n* Thrives in small teams with frequently changing priorities \n* Hard-charging with a sense of urgency\n* Experience using financial analytics to drive strategic decisions\n* Deep alignment with our values and/or a passion for learning and practicing conscious leadership\n* A passion for making an impact on patients\n\n\n\nWhat's in it for you...\n* Ability to work remotely and set your own hours – we care more accomplishing great work, not how many hours or where you work\n* Opportunity to rewrite the standard biotech financing playbook and shape new strategies for a new breed of tech-enabled platform companies\n* Potential to take Verge through an IPO in the next 18 months\n* Stunning colleagues who are leaders in neuroscience drug development and AI\n* A drama-free culture steeped in authenticity, transparency, and vulnerability\n* A true strategic and thought partnership with the Executive Team and CEO\n* A company that values Finance as a strategic rather than administrative function\n* Ground floor seats at a high growth company during a critical inflection point\n* An opportunity to make an impact on millions of patients suffering from the biggest medical challenges of our time\n\n\n\n\n$530,000 - $560,000 a yearCompensation & Benefits at Verge Genomics:Our target starting total cash compensation for successful US-based applicants for this role is $530,000 to $560,000. To determine starting pay, we consider multiple job-related factors including a candidate’s skills, education and experience, the level at which they are actually hired, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.\nThis role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and all employees are offered Equity, subject to the terms of those plans and associated policies.\nIn addition, Verge Genomics also provides our employees:*Excellent medical, dental, and vision coverage*401(k) plan with employer matching for contributions*Disability insurance, Life insurance, Dependent Care FSA and Healthcare FSA*Unlimited paid time off*Paid parental leave*Access to free onsite fitness center*Free snacks and lunch for employees who work onsite*WFH stipend for employees who work remotely\n\nHelp us revolutionize the way drugs are discovered & developed:\nThe startup nature of Verge Genomics provides multiple growth opportunities into other areas of the company. As one of the early employees at Verge, your work will have a direct impact on the foundation of a groundbreaking new drug development model. \n\n#Salary and compensation\n No salary data published by company so we estimated salary based on similar jobs related to Accounting, Education and Finance jobs that are similar:\n\n $80,000 — $150,000/year\n
\n\n#Benefits\n 💰 401(k)\n\n🌎 Distributed team\n\n⏰ Async\n\n🤓 Vision insurance\n\n🦷 Dental insurance\n\n🚑 Medical insurance\n\n🏖 Unlimited vacation\n\n🏖 Paid time off\n\n📆 4 day workweek\n\n💰 401k matching\n\n🏔 Company retreats\n\n🏬 Coworking budget\n\n📚 Learning budget\n\n💪 Free gym membership\n\n🧘 Mental wellness budget\n\n🖥 Home office budget\n\n🥧 Pay in crypto\n\n🥸 Pseudonymous\n\n💰 Profit sharing\n\n💰 Equity compensation\n\n⬜️ No whiteboard interview\n\n👀 No monitoring system\n\n🚫 No politics at work\n\n🎅 We hire old (and young)\n\n
\n\n#Location\nRemote